Michel Bouvier is a world-renowned expert in cell signaling and molecular pharmacology.
Alan Evans is one of the world’s foremost authorities on brain imaging and the modeling of brain networks, and his ground-breaking work has been awarded with many of the field’s most prestigious awards
A significant barrier to cardiac research and the development of new cardiac drug treatments has been a lack of appropriate human cardiac tissue models on which new treatments might be tested.
Stephen W. Scherer has revolutionized our understanding of the human genome through his research at The Hospital for Sick Children and the University of Toronto.
This project seeks to develop new agents that can efficiently enter the brain to enable noninvasive, early detection of neurodegenerative diseases including Alzheimer’s disease.
Dr. Hachinski has transformed the understanding, diagnosis, treatment and prevention of the two greatest threats to the brain: stroke and dementia. He co-discovered a link between Alzheimer’s and stroke and introduced new concepts and a new clinical diagnosis tool.
